The mission of the Office of Translational Research is to facilitate the preclinical discovery and development of new therapeutic interventions for neurological disorders by:
- Supporting preclinical development from the discovery of candidate therapeutics to Investigational New Drug (IND) and Investigational Device Exemption (IDE) applications to the FDA
- Support translational research projects and networks
- Supporting the design, implementation, and management of research infrastructure
More Information on the Translational Research program area.